Epizyme Inks Epigenetics Deal With Celgene; $90M Up Front
Epizyme Inc. is expected to announce early Thursday a broad epigenetics partnership with Celgene Corp. that brings the small biotech $90 million up front, at least $160 million in milestone payments per compound and double-digit royalties.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter